Crossref
Adverse Events of GLP-1 Receptor Agonists for Weight Loss: Twitter and a National Pharmacovigilance Database
Drug Targets and Therapeutics · 2023
DOI: 10.58502/dtt.23.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, 2023. Verfasst von Hyun-Myung Back und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Back, H., Choi, S., & Kim, M. G. (2023). Adverse Events of GLP-1 Receptor Agonists for Weight Loss: Twitter and a National Pharmacovigilance Database. Drug Targets and Therapeutics. https://doi.org/10.58502/dtt.23.0003
Vancouver
Back H, Choi S, Kim MG. Adverse Events of GLP-1 Receptor Agonists for Weight Loss: Twitter and a National Pharmacovigilance Database. Drug Targets and Therapeutics. 2023. doi:10.58502/dtt.23.0003
BibTeX
@article{Back2023,
author = {Back, Hyun-Myung and Choi, Seo-A and Kim, Myeong Gyu},
title = {Adverse Events of GLP-1 Receptor Agonists for Weight Loss: Twitter and a National Pharmacovigilance Database},
journal = {Drug Targets and Therapeutics},
year = {2023},
doi = {10.58502/dtt.23.0003}
}
EUVIMED